Trial
NCT00958412
Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Repros Therapeutics Inc.
Collaborators
—
Condition
Endometriosis
Intervention
Proellex®
Why stopped
Repros stopped the study for safety and FDA put the study on hold for safety.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-02-12